Table 1.

Classification of β-lactam antibacterials, penicillins (J01C; ATC/DDD index 2019)

Extended-spectrum penicillins
J01CA01	Ampicillin
J01CA02	Pivampicillin
J01CA03	Carbenicillin a
J01CA04	Amoxicillin b
J01CA05	Carindacillin a
J01CA06	Bacampicillin
J01CA07	Epicillin a
J01CA08	Pivmecillinam
J01CA09	Azlocillin
J01CA10	Mezlocillin
J01CA11	Mecillinam
J01CA12	Piperacillin
J01CA13	Ticarcillin
J01CA14	Metampicillin a
J01CA15	Talampicillin a
J01CA16	Sulbenicillin a
J01CA17	Temocillina
J01CA18	Hetacillin a
J01CA19	Aspoxicillin a
J01CA20	Combinations a
J01CA51	Ampicillin, combinations
Narrow-spectrum penicillins
J01CE01	Benzylpenicillin
J01CE02	Phenoxymethylpenicillin b
J01CE03	Propicillin
J01CE04	Azidocillin a
J01CE05	Pheneticillin
J01CE06	Penamecillin
J01CE07	Clometocillin
J01CE08	Benzathine benzylpenicillin
J01CE09	Procaine penicillin
J01CE10	phenoxymethylpenicillin
J01CE30	Combinations
Combinations of penicillins, including β-lactamase inhibitors
J01CR01	Ampicillin and BLI
J01CR02	Amoxicillin and BLI b
J01CR03	Ticarcillin and BLI
J01CR04	Sultamicillin
J01CR05	Piperacillin and BLI
J01CR50	Combinations of penicillins
β-Lactamase inhibitors
J01CG01	Sulbactam
J01CG02	Tazobactam a
Penicillinase-resistant penicillins
J01CF01	Dicloxacillin
J01CF02	Cloxacillin
J01CF03	Meticillin a
J01CF04	Oxacillin
J01CF05	Flucloxacillin b
J01CF06	Nafcillin c

BLI, β-lactamase inhibitor; Bold type indicates that consumption was part of the top 90% of the community consumption of penicillins (J01C) in 28 EU/EEA countries in 2017; Italic type indicates that no consumption of this penicillin was reported in 28 EU/EEA countries in 2017.

^aNo consumption of this penicillin was reported in 30 EU/EEA countries in 2009.

^bConsumption was part of the top 90% of community consumption of penicillins (J01C) in 30 EU/EEA countries in 2009.

^cThis penicillin was not included in the ATC/DDD index in 2009 and was therefore not reported in 2009.